search
Back to results

Radial Strain ECHO-Guided Implantation of Cardiac Resynchronization Therapy (RAISE-CRT)

Primary Purpose

Ischemic Cardiomyopathy

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Echo guided implantation group
Sponsored by
Sheba Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ischemic Cardiomyopathy focused on measuring Heart failure, Cardiac Resynchronization Therapy, CRT, Radial strain echocardiography, Ischemic cardiomyopathy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with ischemic CMP based on evidence of prior MI by history, coronary angiography/revascularization or imaging
  • AHA ACC or ESC EHRA Guideline-based indication (Class I or II) for CRT and NYHA class II-IV heart failure
  • ECG wide QRS and :

QRS > 120 msec in NYHA III- IV

OR

CLBBB or QRS > 150 in NYHA =II

  • Sinus rhythm predominant rhythm (PAF not an exclusion)
  • All must be candidates for De novo CRT-D implantation with LV lead via transvenous approach or patients previously implanted with pacemaker or ICD with <20% pacing over the last three months who are undergoing CRT-D upgrade.
  • Patient provides informed consent, tolerate a pectoral implant, agree to comply with the protocol, and maintain scheduled follow-up visits.

Exclusion Criteria:

  • Permanent or persistent atrial fibrillation
  • Advanced renal disease (Cr >=2.5 mg/dL)
  • Advanced comorbidities with life expectancy of <1 year
  • Patients on waiting list for heart transplantation
  • Requiring intravenous amines (continuous or or intermittent amine drip therapy)
  • Severe chronic pulmonary disease (simulating heart failure)
  • Severe (untreated) organic mitral valve disease
  • Poorly treated hypertension
  • History of myocardial infarction < 3 months; unstable angina < 1m, CABG <3 months; PCI <3 months
  • Mechanical TC valve
  • Previously implanted CRT system
  • Poorly visualized cardiac chamber dimensions in an echocardiogram performed prior to enrollment - please help us define
  • Pregnancy or child-bearing potential in the absence of accepted forms of birth control
  • Concurrent enrollment in other study

Sites / Locations

  • Mayo Clinic
  • Barzilai Medical Center
  • Carmel Medical Center
  • Rambam Medical Center
  • Shaare Zedek
  • Rabin Medical Center
  • Sheba Medical Center
  • Kaplan Medical Center
  • Sorasky Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Echo guided implantation group

Conventional implantation group

Arm Description

Echo guided implantation group Patients undergoing speckle tracking based LV lead implantation.

Patients undergoing conventional LV lead implantation

Outcomes

Primary Outcome Measures

Demonstrating Percent reduction in left ventricular end systolic (LVESV) at 6 months compared with baseline values.
To show that in patients with ischemic cardiomyopathy, implantation of a CRT LV lead guided by radial strain imaging results in a significantly greater echocardiographic and clinical response to cardiac resynchronization therapy compared with conventional implantation techniques.

Secondary Outcome Measures

Clinical Improvement
A combined clinical event rate - change in NYHA, hospitalization for heart failure, death
Echocardiographic improvement
>15% improvement in LVESV, >10% improvement in LVEDV, 5% absolute improvement of LVEF
Improvement in wellbeing
10 point improvement in Minnesota Living with Heart Failure Questionnaire (MLWHF), 10% improvement of 6 minute walk test(6MWT)

Full Information

First Posted
May 14, 2012
Last Updated
October 18, 2017
Sponsor
Sheba Medical Center
Collaborators
Tel-Aviv Sourasky Medical Center, Rabin Medical Center, Rambam Health Care Campus, Kaplan Medical Center, Soroka University Medical Center, Mayo Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT01603706
Brief Title
Radial Strain ECHO-Guided Implantation of Cardiac Resynchronization Therapy
Acronym
RAISE-CRT
Official Title
Radial Strain Imaging-Guided Lead Placement for Improving Response to Cardiac Resynchronization Therapy in Patients With Ischemic Cardiomyopathy: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
October 2017 (Actual)
Study Completion Date
October 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sheba Medical Center
Collaborators
Tel-Aviv Sourasky Medical Center, Rabin Medical Center, Rambam Health Care Campus, Kaplan Medical Center, Soroka University Medical Center, Mayo Clinic

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the use of radial strain imaging using speckle tracking analysis to predict the response to CRT in patients with ischemic cardiomyopathy (ICMP) with NYHA functional class 2-4 heart failure and a standard guideline-based CRT indication. Thus assessing the value of lead localization determined by radial strain imaging in a prospective, randomized manner.
Detailed Description
In this study we propose to evaluate the utility of radial strain imaging using speckle tracking to predict the response to CRT in patients with ischemic cardiomyopathy (ICMP) with NYHA functional class 2-4 heart failure and a standard guideline-based CRT indication, and to determine the value of lead localization determined by radial strain imaging in a prospective, randomized manner. We will compare two randomized groups of CRT recipients implanted with CRT-D systems. In the control group, implantation will be performed in the usual manner and the lead will be placed at the discretion of the implanting physician, preferably at posterolateral LV sites . In the study group, leads will be placed in areas of latest contraction that lack significant scar, as determined by speckle tracking imaging. The primary outcome measure for comparison between the 2 groups will be echocardiographic response (as assessed by percent reduction in left ventricular end systolic volumes) at 6 months post-implantation. In addition, clinical response parameters will also be measured as secondary end points. We hypothesize that 1) patients showing greater dyssynchrony and/or discoordination index with speckle tracking will derive a significantly greater response to cardiac resynchronization therapy; and 2) patients allocated to the image-guided LV lead placement group will derive a significantly greater response to CRT than patients in the non- guided implantation (control) group. If radial strain imaging proves useful for improving the CRT response rate and identification of patients likely to respond, it will have important clinical and economic implications by improving individual outcomes and more effective utilization of constrained health care resources. Furthermore, if echo-guided lead implantation proves to be effective in reducing the relatively large non-response rate to cardiac resynchronization therapy, it will likely result in increased device utilization among eligible heart failure patients. Specific Aims Aim #1: To show that in patients with ischemic cardiomyopathy, implantation of a CRT LV lead guided by radial strain imaging results in a significantly greater echocardiographic and clinical response to cardiac resynchronization therapy compared with conventional implantation techniques. Aim #2: To show that speckle tracking strain data can be used to identify the degree of echocardiographic response to CRT, using both dyssynchrony (time to peak strain ) and discoordination indices. Aim #3: The Paieon substudy will comprise 40 patients enrolled at 3 centers, for whom additional information mechanical dyssynchrony, using the Paieon CardioGuide motion map, will be collected during device implantation as detailed below The primary aim of the study is to relate data of mechanical dyssynchrony obtained from angiography through the Paieon CardioGuide motion map to dyssynchrony data obtained from the echocardiogram. The dyssynchrony data will not be available to the treating physicians and will not be used to direct the LV lead location.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Cardiomyopathy
Keywords
Heart failure, Cardiac Resynchronization Therapy, CRT, Radial strain echocardiography, Ischemic cardiomyopathy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
172 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Echo guided implantation group
Arm Type
Active Comparator
Arm Description
Echo guided implantation group Patients undergoing speckle tracking based LV lead implantation.
Arm Title
Conventional implantation group
Arm Type
No Intervention
Arm Description
Patients undergoing conventional LV lead implantation
Intervention Type
Procedure
Intervention Name(s)
Echo guided implantation group
Intervention Description
Lead placement according echo strain imaging result
Primary Outcome Measure Information:
Title
Demonstrating Percent reduction in left ventricular end systolic (LVESV) at 6 months compared with baseline values.
Description
To show that in patients with ischemic cardiomyopathy, implantation of a CRT LV lead guided by radial strain imaging results in a significantly greater echocardiographic and clinical response to cardiac resynchronization therapy compared with conventional implantation techniques.
Time Frame
within 12 month from enrollment.
Secondary Outcome Measure Information:
Title
Clinical Improvement
Description
A combined clinical event rate - change in NYHA, hospitalization for heart failure, death
Time Frame
Within 12 month from enrollment
Title
Echocardiographic improvement
Description
>15% improvement in LVESV, >10% improvement in LVEDV, 5% absolute improvement of LVEF
Time Frame
Within 12 month from enrollment
Title
Improvement in wellbeing
Description
10 point improvement in Minnesota Living with Heart Failure Questionnaire (MLWHF), 10% improvement of 6 minute walk test(6MWT)
Time Frame
Within 12 month from enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with ischemic CMP based on evidence of prior MI by history, coronary angiography/revascularization or imaging AHA ACC or ESC EHRA Guideline-based indication (Class I or II) for CRT and NYHA class II-IV heart failure ECG wide QRS and : QRS > 120 msec in NYHA III- IV OR CLBBB or QRS > 150 in NYHA =II Sinus rhythm predominant rhythm (PAF not an exclusion) All must be candidates for De novo CRT-D implantation with LV lead via transvenous approach or patients previously implanted with pacemaker or ICD with <20% pacing over the last three months who are undergoing CRT-D upgrade. Patient provides informed consent, tolerate a pectoral implant, agree to comply with the protocol, and maintain scheduled follow-up visits. Exclusion Criteria: Permanent or persistent atrial fibrillation Advanced renal disease (Cr >=2.5 mg/dL) Advanced comorbidities with life expectancy of <1 year Patients on waiting list for heart transplantation Requiring intravenous amines (continuous or or intermittent amine drip therapy) Severe chronic pulmonary disease (simulating heart failure) Severe (untreated) organic mitral valve disease Poorly treated hypertension History of myocardial infarction < 3 months; unstable angina < 1m, CABG <3 months; PCI <3 months Mechanical TC valve Previously implanted CRT system Poorly visualized cardiac chamber dimensions in an echocardiogram performed prior to enrollment - please help us define Pregnancy or child-bearing potential in the absence of accepted forms of birth control Concurrent enrollment in other study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ilan Goldenberg, Prof.
Organizational Affiliation
The Israeli Society for the Prevention of Heart Attacks
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Michael Glikson, Prof.
Organizational Affiliation
Sheba Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Paul Friedman, Prof.
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Facility Name
Barzilai Medical Center
City
Ashkelon
Country
Israel
Facility Name
Carmel Medical Center
City
Haifa
Country
Israel
Facility Name
Rambam Medical Center
City
Haifa
Country
Israel
Facility Name
Shaare Zedek
City
Jerusalem
Country
Israel
Facility Name
Rabin Medical Center
City
Petah Tikva
Country
Israel
Facility Name
Sheba Medical Center
City
Ramat Gan
Country
Israel
Facility Name
Kaplan Medical Center
City
Rehovot
Country
Israel
Facility Name
Sorasky Medical Center
City
Tel Aviv
Country
Israel

12. IPD Sharing Statement

Citations:
PubMed Identifier
20709721
Citation
Yu CM, Sanderson JE, Gorcsan J 3rd. Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy. Eur Heart J. 2010 Oct;31(19):2326-37. doi: 10.1093/eurheartj/ehq263. Epub 2010 Aug 13.
Results Reference
background
PubMed Identifier
20647479
Citation
Miyazaki C, Redfield MM, Powell BD, Lin GM, Herges RM, Hodge DO, Olson LJ, Hayes DL, Espinosa RE, Rea RF, Bruce CJ, Nelson SM, Miller FA, Oh JK. Dyssynchrony indices to predict response to cardiac resynchronization therapy: a comprehensive prospective single-center study. Circ Heart Fail. 2010 Sep;3(5):565-73. doi: 10.1161/CIRCHEARTFAILURE.108.848085. Epub 2010 Jul 20.
Results Reference
background
PubMed Identifier
18458170
Citation
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.
Results Reference
background
PubMed Identifier
21173353
Citation
Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, Nucifora G, van de Veire NR, Ypenburg C, Boersma E, Holman ER, Schalij MJ, Bax JJ. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation. 2011 Jan 4;123(1):70-8. doi: 10.1161/CIRCULATIONAHA.110.945345. Epub 2010 Dec 20.
Results Reference
background
PubMed Identifier
17035253
Citation
Becker M, Hoffmann R, Kuhl HP, Grawe H, Katoh M, Kramann R, Bucker A, Hanrath P, Heussen N. Analysis of myocardial deformation based on ultrasonic pixel tracking to determine transmurality in chronic myocardial infarction. Eur Heart J. 2006 Nov;27(21):2560-6. doi: 10.1093/eurheartj/ehl288. Epub 2006 Oct 11.
Results Reference
background
PubMed Identifier
18482662
Citation
Delgado V, Ypenburg C, van Bommel RJ, Tops LF, Mollema SA, Marsan NA, Bleeker GB, Schalij MJ, Bax JJ. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol. 2008 May 20;51(20):1944-52. doi: 10.1016/j.jacc.2008.02.040.
Results Reference
background
PubMed Identifier
20530502
Citation
Tanaka H, Nesser HJ, Buck T, Oyenuga O, Janosi RA, Winter S, Saba S, Gorcsan J 3rd. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J. 2010 Jul;31(14):1690-700. doi: 10.1093/eurheartj/ehq213. Epub 2010 Jun 8.
Results Reference
background
PubMed Identifier
18515652
Citation
Kirn B, Jansen A, Bracke F, van Gelder B, Arts T, Prinzen FW. Mechanical discoordination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization. Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H640-6. doi: 10.1152/ajpheart.00106.2008. Epub 2008 May 30.
Results Reference
background
PubMed Identifier
20418055
Citation
Wang CL, Wu CT, Yeh YH, Wu LS, Chang CJ, Ho WJ, Hsu LA, Luqman N, Kuo CT. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy. J Am Soc Echocardiogr. 2010 Jun;23(6):611-20. doi: 10.1016/j.echo.2010.03.012. Epub 2010 Apr 24.
Results Reference
background
PubMed Identifier
22411692
Citation
Wang CL, Powell BD, Redfield MM, Miyazaki C, Fine NM, Olson LJ, Cha YM, Espinosa RE, Hayes DL, Hodge DO, Lin G, Friedman PA, Oh JK. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy. Eur J Heart Fail. 2012 May;14(5):517-25. doi: 10.1093/eurjhf/hfs025. Epub 2012 Mar 12.
Results Reference
background
PubMed Identifier
21321181
Citation
Sung RK, Foster E. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful. Circulation. 2011 Feb 15;123(6):656-62. doi: 10.1161/CIRCULATIONAHA.110.954420. No abstract available.
Results Reference
background
PubMed Identifier
9358487
Citation
Kindermann M, Frohlig G, Doerr T, Schieffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 1):2453-62. doi: 10.1111/j.1540-8159.1997.tb06085.x.
Results Reference
background

Learn more about this trial

Radial Strain ECHO-Guided Implantation of Cardiac Resynchronization Therapy

We'll reach out to this number within 24 hrs